covid 19 News and Research

RSS

COVID-19 incinerators set new record for merseyside manufacturer

A global waste management specialist has completed its first ever air-freighted incinerator system in record time, to help United Arab Emirates hospitals manage Coronavirus-infected waste.

From Inciner8 Limited 1 Apr 2022

Managing hazardous waste during the Covid-19 pandemic

In a hospital or medical environment, preventing and delaying the spread of Coronavirus goes far beyond washing hands. Good biosecurity is essential, and the safe disposal of infected waste will save lives.

From Inciner8 Limited 1 Apr 2022

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Faculty from the Departments of Microbiology, Medicine Genetics and Genomic Sciences, and Pathology and Molecular Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai play key roles in a National Institutes of Health (NIH) program set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program, called SARS-CoV-2 Assessment of Viral Evolution (SAVE) and described in a paper published March 31 in Nature, assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

31 Mar 2022

The longest duration of SARS-CoV-2 positivity after initial diagnosis

An immunocompetent individual with prolonged SARS-CoV-2 shedding 221 days after their initial COVID-19 diagnosis.

31 Mar 2022

The mucosal antibody response to SARS-CoV-2

Researchers determine mucosal SARS-CoV-2-specific antibody levels and their neutralizing effect in pediatric and adult patients.

31 Mar 2022

How effective are household cleaning agents against SARS-CoV-2?

Researchers analyze commonly available household cleaning products to determine the most effective virucidal agent against SARS-CoV-2.

31 Mar 2022

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

Early treatment of newly diagnosed COVID-19 patients with plasma extracted from individuals who have recovered from the disease reduces the need for hospitalization by more than 50%, according to a new nationwide clinical trial.

31 Mar 2022

UIC researchers projected to receive $22 million to study long COVID-19

A team of University of Illinois Chicago researchers is projected to receive approximately $22 million from the National Institutes of Health over four years to research long COVID-19.

31 Mar 2022

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

Data continue to show the importance of vaccination and booster doses to protect individuals both from infection and severe outcomes of COVID-19.

31 Mar 2022

Waiver will continue to be applied for COVID-19 antiviral medicines and therapeutic treatments

We are pleased to announce that the arrangements that were made for the purposes of regulation 13 of the National Health Service (Charges for Drugs and Appliances) Regulations 2015, for antiviral medicines to be supplied for free to patients who have tested positive for COVID-19 and who are eligible to receive antiviral treatments for COVID-19 via Covid Medicines Delivery Units (CMDUs), will be extended until 31st March 2023.

31 Mar 2022

KHN’s ‘What the Health?’: Funding for the next pandemic

President Joe Biden released his budget proposal for 2023 this week, and it calls for a nearly 27% increase in funding for the Department of Health and Human Services.

31 Mar 2022

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States.

31 Mar 2022

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

A new study investigated the impact of pre-existing SARS-CoV-2 infection-induced immunity on vaccine-induced immunity.

31 Mar 2022

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

In a new study, researchers determined the risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated individuals.

31 Mar 2022

Study identifies implications of long-COVID on long term physical and mental health

A new study assessed the characteristics of persistent COVID-19 symptoms lasting beyond six months in some COVID-19 patients.

31 Mar 2022

3D Printing Testicular Cells to Treat Infertility

In this interview, we speak to Dr. Ryan Flannigan about his latest research that involved the 3D printing of sperm cells to help treat male infertility.

31 Mar 2022

Impact of racial disparities on COVID-19 outcomes

A new study investigated the racial disparities in COVID-19 outcomes in Black and White patients diagnosed with cancer.

31 Mar 2022

Study estimates the comparative abundance of SARS-CoV-2 variants via wastewater monitoring

A recent study estimated the comparative abundance of SARS-CoV-2 variants via wastewater monitoring.

31 Mar 2022

Study determines the molecular signatures of monocytes and regulatory T cells in the circulating blood of COVID-19 patients

Researchers examined the unique clusters of monocytes and regulatory T cells in the circulating blood from convalescent COVID-19 patients over a prolonged period after recovery, using scRNA sequencing.

31 Mar 2022

MERS-CoV-related viruses invade host cells via bat angiotensin-converting enzyme 2 receptors

A recent study discovered that near relatives of MERS-CoV utilize ACE2 as functional receptors.

31 Mar 2022

covid 19 News and Research

COVID-19 incinerators set new record for merseyside manufacturer

Managing hazardous waste during the Covid-19 pandemic

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

The longest duration of SARS-CoV-2 positivity after initial diagnosis

The mucosal antibody response to SARS-CoV-2

How effective are household cleaning agents against SARS-CoV-2?

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

UIC researchers projected to receive $22 million to study long COVID-19

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

Waiver will continue to be applied for COVID-19 antiviral medicines and therapeutic treatments

KHN’s ‘What the Health?’: Funding for the next pandemic

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

Study identifies implications of long-COVID on long term physical and mental health

3D Printing Testicular Cells to Treat Infertility

Impact of racial disparities on COVID-19 outcomes

Study estimates the comparative abundance of SARS-CoV-2 variants via wastewater monitoring

Study determines the molecular signatures of monocytes and regulatory T cells in the circulating blood of COVID-19 patients

MERS-CoV-related viruses invade host cells via bat angiotensin-converting enzyme 2 receptors

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News